| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 19 | 2016 | 563 | 1.650 |
Why?
|
| VDJ Recombinases | 7 | 2008 | 10 | 1.130 |
Why?
|
| Hematopoietic Stem Cells | 10 | 2015 | 299 | 0.970 |
Why?
|
| Lymphopoiesis | 6 | 2013 | 27 | 0.850 |
Why?
|
| Cell Differentiation | 11 | 2015 | 1386 | 0.520 |
Why?
|
| Aging | 5 | 2017 | 771 | 0.500 |
Why?
|
| Adaptive Immunity | 1 | 2017 | 105 | 0.480 |
Why?
|
| B-Lymphocyte Subsets | 5 | 2011 | 44 | 0.470 |
Why?
|
| Lymphoid Progenitor Cells | 3 | 2013 | 6 | 0.460 |
Why?
|
| Diet | 1 | 2017 | 536 | 0.390 |
Why?
|
| Mice | 34 | 2023 | 11119 | 0.370 |
Why?
|
| Cell Lineage | 7 | 2015 | 282 | 0.320 |
Why?
|
| Flow Cytometry | 11 | 2015 | 663 | 0.310 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2013 | 47 | 0.300 |
Why?
|
| Cell Proliferation | 9 | 2014 | 1038 | 0.300 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2009 | 12 | 0.300 |
Why?
|
| Animals | 36 | 2023 | 21345 | 0.290 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2014 | 67 | 0.260 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2014 | 226 | 0.250 |
Why?
|
| Mice, Transgenic | 11 | 2019 | 1290 | 0.250 |
Why?
|
| Mice, Inbred C57BL | 18 | 2015 | 3485 | 0.240 |
Why?
|
| TCF Transcription Factors | 1 | 2005 | 6 | 0.240 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2005 | 13 | 0.240 |
Why?
|
| DNA-Binding Proteins | 6 | 2013 | 1225 | 0.230 |
Why?
|
| Bacterial Capsules | 1 | 2005 | 18 | 0.230 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 129 | 0.230 |
Why?
|
| Streptococcus pneumoniae | 1 | 2005 | 67 | 0.220 |
Why?
|
| T-Lymphocytes | 7 | 2013 | 1008 | 0.220 |
Why?
|
| Bone Marrow | 2 | 2013 | 176 | 0.220 |
Why?
|
| Bone Marrow Cells | 1 | 2005 | 237 | 0.220 |
Why?
|
| YY1 Transcription Factor | 2 | 2016 | 13 | 0.220 |
Why?
|
| Antigens, T-Independent | 1 | 2004 | 7 | 0.220 |
Why?
|
| Mice, Knockout | 14 | 2013 | 2157 | 0.210 |
Why?
|
| Borrelia Infections | 1 | 2004 | 12 | 0.210 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 28 | 0.210 |
Why?
|
| Signal Transduction | 10 | 2019 | 3153 | 0.210 |
Why?
|
| Immunity, Cellular | 1 | 2004 | 170 | 0.200 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2024 | 93 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2011 | 341 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2014 | 113 | 0.190 |
Why?
|
| Immunologic Memory | 1 | 2004 | 284 | 0.180 |
Why?
|
| Receptors, Antigen, B-Cell | 3 | 2009 | 59 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2024 | 191 | 0.180 |
Why?
|
| Burkitt Lymphoma | 1 | 2023 | 74 | 0.180 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2023 | 105 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 210 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 3 | 2005 | 513 | 0.150 |
Why?
|
| Germinal Center | 2 | 2016 | 39 | 0.140 |
Why?
|
| Viral Tropism | 1 | 2019 | 55 | 0.140 |
Why?
|
| Cytomegalovirus | 1 | 2019 | 94 | 0.140 |
Why?
|
| Multiprotein Complexes | 1 | 2019 | 156 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 350 | 0.130 |
Why?
|
| Homeodomain Proteins | 4 | 2008 | 277 | 0.130 |
Why?
|
| Viral Proteins | 1 | 2019 | 270 | 0.130 |
Why?
|
| Adipocytes | 1 | 2019 | 273 | 0.130 |
Why?
|
| Adipose Tissue | 1 | 2019 | 299 | 0.120 |
Why?
|
| DNA Primers | 3 | 2008 | 301 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 413 | 0.120 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 1630 | 0.120 |
Why?
|
| Fetal Stem Cells | 1 | 2015 | 3 | 0.120 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2015 | 12 | 0.120 |
Why?
|
| Cells, Cultured | 8 | 2015 | 2188 | 0.120 |
Why?
|
| Ethanol | 1 | 2019 | 330 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2015 | 353 | 0.110 |
Why?
|
| Hematopoiesis | 2 | 2013 | 127 | 0.110 |
Why?
|
| Microbiota | 1 | 2017 | 169 | 0.110 |
Why?
|
| Azepines | 1 | 2014 | 22 | 0.110 |
Why?
|
| Triazoles | 1 | 2014 | 63 | 0.100 |
Why?
|
| Apoptosis | 2 | 2016 | 1098 | 0.100 |
Why?
|
| Immunoglobulin M | 2 | 2004 | 116 | 0.100 |
Why?
|
| Macrophages | 1 | 2019 | 1038 | 0.100 |
Why?
|
| Lymphocyte Subsets | 2 | 2011 | 37 | 0.100 |
Why?
|
| Germ-Line Mutation | 1 | 2013 | 47 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2014 | 583 | 0.100 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2013 | 10 | 0.100 |
Why?
|
| V(D)J Recombination | 1 | 2013 | 5 | 0.100 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 132 | 0.100 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2013 | 34 | 0.100 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 82 | 0.100 |
Why?
|
| Point Mutation | 1 | 2013 | 168 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 140 | 0.090 |
Why?
|
| Thymus Gland | 3 | 2011 | 240 | 0.090 |
Why?
|
| Adoptive Transfer | 3 | 2010 | 145 | 0.090 |
Why?
|
| Metalloproteins | 1 | 2011 | 13 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 49 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 67 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2013 | 345 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2013 | 302 | 0.080 |
Why?
|
| Fluorouracil | 1 | 2011 | 68 | 0.080 |
Why?
|
| Wnt Proteins | 2 | 2008 | 104 | 0.080 |
Why?
|
| Endonucleases | 1 | 2011 | 84 | 0.080 |
Why?
|
| Luminescent Proteins | 2 | 2015 | 129 | 0.080 |
Why?
|
| CD4 Antigens | 1 | 2010 | 149 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 3 | 2011 | 372 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 318 | 0.080 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2009 | 3 | 0.080 |
Why?
|
| B-Cell Activation Factor Receptor | 1 | 2009 | 5 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2009 | 16 | 0.080 |
Why?
|
| MEF2 Transcription Factors | 1 | 2009 | 10 | 0.070 |
Why?
|
| Mice, Inbred Strains | 2 | 2011 | 185 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2023 | 1565 | 0.070 |
Why?
|
| Lymphoma, B-Cell | 2 | 2012 | 63 | 0.070 |
Why?
|
| Chromosomal Instability | 1 | 2008 | 20 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 542 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 88 | 0.070 |
Why?
|
| Gene Rearrangement | 1 | 2008 | 41 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 604 | 0.070 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2007 | 20 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2008 | 127 | 0.070 |
Why?
|
| Glioma | 1 | 2008 | 101 | 0.070 |
Why?
|
| Enzyme Inhibitors | 2 | 2024 | 367 | 0.070 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2007 | 64 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2009 | 321 | 0.060 |
Why?
|
| Diglycerides | 1 | 2006 | 24 | 0.060 |
Why?
|
| Dendritic Cells | 2 | 2008 | 531 | 0.060 |
Why?
|
| Humans | 12 | 2024 | 65140 | 0.060 |
Why?
|
| Recombination, Genetic | 2 | 2008 | 256 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2008 | 220 | 0.060 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2006 | 12 | 0.060 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2005 | 5 | 0.060 |
Why?
|
| Interleukin-7 | 2 | 2003 | 29 | 0.060 |
Why?
|
| Base Sequence | 2 | 2008 | 1332 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 318 | 0.060 |
Why?
|
| Calcium Signaling | 1 | 2006 | 164 | 0.060 |
Why?
|
| Virulence | 1 | 2005 | 199 | 0.050 |
Why?
|
| Azacitidine | 1 | 2024 | 15 | 0.050 |
Why?
|
| Time Factors | 3 | 2010 | 3762 | 0.050 |
Why?
|
| Glycine | 1 | 2024 | 48 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2013 | 919 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 44 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 790 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2003 | 35 | 0.050 |
Why?
|
| Pyridines | 1 | 2024 | 119 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 450 | 0.050 |
Why?
|
| Relapsing Fever | 1 | 2003 | 16 | 0.050 |
Why?
|
| Liver | 2 | 2019 | 871 | 0.050 |
Why?
|
| Disease Management | 1 | 2024 | 235 | 0.050 |
Why?
|
| Rituximab | 1 | 2023 | 89 | 0.050 |
Why?
|
| Immunophenotyping | 2 | 2013 | 194 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 450 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 2023 | 199 | 0.040 |
Why?
|
| Mutation | 2 | 2024 | 2661 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 464 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 2293 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2011 | 104 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 401 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 643 | 0.040 |
Why?
|
| A549 Cells | 1 | 2019 | 39 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 94 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 215 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2019 | 541 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 616 | 0.030 |
Why?
|
| Wnt-5a Protein | 2 | 2008 | 8 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2013 | 753 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2013 | 907 | 0.030 |
Why?
|
| Spleen | 2 | 2010 | 474 | 0.030 |
Why?
|
| Cell Survival | 2 | 2009 | 587 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2008 | 962 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2008 | 241 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2015 | 241 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 154 | 0.030 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 18 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 203 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2013 | 71 | 0.030 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2013 | 2 | 0.020 |
Why?
|
| Deoxyribonuclease I | 1 | 2013 | 41 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 121 | 0.020 |
Why?
|
| Transgenes | 1 | 2013 | 204 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 158 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2012 | 7 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2013 | 342 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2013 | 117 | 0.020 |
Why?
|
| Inflammation | 1 | 2019 | 1192 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2013 | 133 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 103 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 119 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 53 | 0.020 |
Why?
|
| CpG Islands | 1 | 2013 | 219 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 154 | 0.020 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2011 | 22 | 0.020 |
Why?
|
| Female | 5 | 2014 | 34018 | 0.020 |
Why?
|
| LIM Domain Proteins | 1 | 2011 | 32 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 167 | 0.020 |
Why?
|
| Multifunctional Enzymes | 1 | 2011 | 19 | 0.020 |
Why?
|
| Myelopoiesis | 1 | 2011 | 13 | 0.020 |
Why?
|
| Obesity | 1 | 2019 | 1274 | 0.020 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2011 | 76 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2011 | 96 | 0.020 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2011 | 27 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 415 | 0.020 |
Why?
|
| Male | 4 | 2014 | 31047 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 178 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2011 | 195 | 0.020 |
Why?
|
| Histones | 1 | 2013 | 494 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2013 | 663 | 0.020 |
Why?
|
| Inhibitor of Growth Protein 1 | 1 | 2008 | 4 | 0.020 |
Why?
|
| DNA Repair | 1 | 2011 | 262 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2010 | 281 | 0.020 |
Why?
|
| Nestin | 1 | 2008 | 13 | 0.020 |
Why?
|
| Wnt3 Protein | 1 | 2008 | 3 | 0.020 |
Why?
|
| Wnt3A Protein | 1 | 2008 | 3 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2008 | 19 | 0.020 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 17 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 48 | 0.020 |
Why?
|
| Growth Inhibitors | 1 | 2008 | 24 | 0.020 |
Why?
|
| DNA Damage | 1 | 2011 | 297 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 99 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2011 | 440 | 0.020 |
Why?
|
| Retroviridae | 1 | 2008 | 75 | 0.020 |
Why?
|
| Integrases | 1 | 2008 | 41 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 341 | 0.020 |
Why?
|
| Centrosome | 1 | 2008 | 72 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 14 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2008 | 286 | 0.020 |
Why?
|
| CD56 Antigen | 1 | 2008 | 16 | 0.020 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 15 | 0.020 |
Why?
|
| Cell Communication | 1 | 2008 | 133 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2008 | 205 | 0.020 |
Why?
|
| Adult | 1 | 2024 | 17358 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2008 | 611 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2010 | 641 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 676 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 428 | 0.010 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2005 | 24 | 0.010 |
Why?
|
| Estrogens | 1 | 2006 | 115 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2006 | 257 | 0.010 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2005 | 61 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2006 | 154 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 630 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2005 | 110 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1163 | 0.010 |
Why?
|
| Cell Line | 1 | 2008 | 2024 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2003 | 17 | 0.010 |
Why?
|
| Hematopoietic System | 1 | 2003 | 10 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2003 | 54 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2003 | 25 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 5792 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2003 | 80 | 0.010 |
Why?
|
| Lymphopenia | 1 | 2003 | 35 | 0.010 |
Why?
|
| Blood Bactericidal Activity | 1 | 2003 | 61 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 240 | 0.010 |
Why?
|
| Borrelia | 1 | 2003 | 31 | 0.010 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2002 | 16 | 0.010 |
Why?
|
| Phenotype | 1 | 2006 | 1233 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 301 | 0.010 |
Why?
|
| Bacteremia | 1 | 2003 | 91 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2003 | 518 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 391 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 426 | 0.010 |
Why?
|
| Calcium | 1 | 2003 | 584 | 0.010 |
Why?
|
| Brain | 1 | 2008 | 1605 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2003 | 827 | 0.010 |
Why?
|